Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 520

1.

Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland.

Botteri E, Støer NC, Weiderpass E, Pukkala E, Ylikorkala O, Lyytinen H.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1857-1860. doi: 10.1158/1055-9965.EPI-19-0554. Epub 2019 Aug 27.

PMID:
31455672
2.

Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study.

Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

BMJ. 2019 Mar 6;364:l665. doi: 10.1136/bmj.l665.

3.

Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse.

Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS.

Menopause. 2019 Feb;26(2):140-144. doi: 10.1097/GME.0000000000001173.

PMID:
29994974
4.

Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy.

Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS.

Int Urogynecol J. 2019 Feb;30(2):251-256. doi: 10.1007/s00192-018-3682-7. Epub 2018 Jun 26.

PMID:
29946829
5.

Increased cardiac and stroke death risk in the first year after discontinuation of postmenopausal hormone therapy.

Venetkoski M, Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Menopause. 2018 Apr;25(4):375-379. doi: 10.1097/GME.0000000000001023.

PMID:
29112596
6.

Vasomotor hot flashes and cardiac repolarization: a randomized placebo-controlled trial of postmenopausal hormone therapy.

Lantto H, Haapalahti P, Viitasalo M, Väänänen H, Sovijärvi ARA, Ylikorkala O, Mikkola TS.

Menopause. 2017 Dec;24(12):1386-1391. doi: 10.1097/GME.0000000000000932.

PMID:
28697043
7.

New evidence for cardiac benefit of postmenopausal hormone therapy.

Mikkola TS, Savolainen-Peltonen H, Venetkoski M, Ylikorkala O.

Climacteric. 2017 Feb;20(1):5-10. doi: 10.1080/13697137.2016.1262839. Epub 2017 Jan 2. Review.

PMID:
28042727
8.

Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users.

Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):870-877. doi: 10.1210/jc.2016-3590.

PMID:
27906568
9.

Decreased mortality risk due to first acute coronary syndrome in women with postmenopausal hormone therapy use.

Tuomikoski P, Salomaa V, Havulinna A, Airaksinen J, Ketonen M, Koukkunen H, Ukkola O, Kesäniemi YA, Lyytinen H, Ylikorkala O, Mikkola TS.

Maturitas. 2016 Dec;94:106-109. doi: 10.1016/j.maturitas.2016.09.015. Epub 2016 Sep 28.

PMID:
27823727
10.

Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study.

Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Menopause. 2016 Nov;23(11):1199-1203.

PMID:
27465718
11.

Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies.

Savolainen-Peltonen H, Tuomikoski P, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

J Clin Endocrinol Metab. 2016 Jul;101(7):2794-801. doi: 10.1210/jc.2015-4149. Epub 2016 May 12.

PMID:
27172432
12.

Vaginal estradiol use and the risk for cardiovascular mortality.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Hum Reprod. 2016 Apr;31(4):804-9. doi: 10.1093/humrep/dew014. Epub 2016 Feb 13.

PMID:
26874358
13.

Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

J Clin Endocrinol Metab. 2015 Dec;100(12):4588-94. doi: 10.1210/jc.2015-1864. Epub 2015 Sep 28.

PMID:
26414962
14.

The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study.

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Maturitas. 2015 Jul;81(3):384-8. doi: 10.1016/j.maturitas.2015.04.002. Epub 2015 Apr 13.

PMID:
25912424
15.

Postmenopausal hormone therapy-also use of estradiol plus levonorgestrel-intrauterine system is associated with an increased risk of primary fallopian tube carcinoma.

Koskela-Niska V, Pukkala E, Lyytinen H, Ylikorkala O, Dyba T.

Int J Cancer. 2015 Oct 15;137(8):1947-52. doi: 10.1002/ijc.29549. Epub 2015 Apr 21.

16.

Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality.

Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O.

Menopause. 2015 Sep;22(9):976-83. doi: 10.1097/GME.0000000000000450.

PMID:
25803671
17.

[Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative].

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Duodecim. 2014;130(21):2209. Finnish. No abstract available.

PMID:
25582016
18.

Coronary heart disease mortality and hormone therapy before and after the Women's Health Initiative.

Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.

Obstet Gynecol. 2014 Nov;124(5):947-53. doi: 10.1097/AOG.0000000000000461.

PMID:
25437723
19.

Postmenopausal hot flushes and bone mineral density: a longitudinal study.

Tuomikoski P, Ylikorkala O, Mikkola TS.

Acta Obstet Gynecol Scand. 2015 Feb;94(2):198-203. doi: 10.1111/aogs.12546. Epub 2014 Dec 25.

PMID:
25421213
20.

Premenstrual symptoms in fertile age are associated with impaired quality of life, but not hot flashes, in recently postmenopausal women.

Hautamäki H, Haapalahti P, Savolainen-Peltonen H, Tuomikoski P, Ylikorkala O, Mikkola TS.

Menopause. 2014 Dec;21(12):1287-91. doi: 10.1097/GME.0000000000000247.

PMID:
24824645

Supplemental Content

Loading ...
Support Center